1. Report Introduction
2. Spinocerebellar Ataxia (SCA) Epidemiology Overview at a Glance
3. Market Share Distribution of Spinocerebellar Ataxia (SCA)
4. Disease Background and Overview: Spinocerebellar Ataxia (SCA)
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Spinocerebellar Ataxia (SCA) Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Spinocerebellar Ataxia (SCA) by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Spinocerebellar Ataxia (SCA)
7.3. Sub-Type Specific cases of Spinocerebellar Ataxia (SCA)*
7.4. Sex- Specific Cases of Spinocerebellar Ataxia (SCA)*
7.5. Diagnosed Cases of Spinocerebellar Ataxia (SCA)
7.6. Treated Cases of Spinocerebellar Ataxia (SCA)
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Spinocerebellar Ataxia (SCA)
8.1.3. Sub-Type Specific cases of Spinocerebellar Ataxia (SCA)*
8.1.4. Sex- Specific Cases of Spinocerebellar Ataxia (SCA)*
8.1.5. Diagnosed Cases of Spinocerebellar Ataxia (SCA)
8.1.6. Treated Cases of Spinocerebellar Ataxia (SCA)
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Spinocerebellar Ataxia (SCA)
8.2.3. Sub-Type Specific cases of Spinocerebellar Ataxia (SCA)*
8.2.4. Sex- Specific Cases of Spinocerebellar Ataxia (SCA)*
8.2.5. Diagnosed Cases of Spinocerebellar Ataxia (SCA)
8.2.6. Treated Cases of Spinocerebellar Ataxia (SCA)
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Spinocerebellar Ataxia (SCA)
8.3.3. Sub-Type Specific cases of Spinocerebellar Ataxia (SCA)*
8.3.4. Sex- Specific Cases of Spinocerebellar Ataxia (SCA)*
8.3.5. Diagnosed Cases of Spinocerebellar Ataxia (SCA)
8.3.6. Treated Cases of Spinocerebellar Ataxia (SCA)
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Spinocerebellar Ataxia (SCA)
8.4.3. Sub-Type Specific cases of Spinocerebellar Ataxia (SCA)*
8.4.4. Sex- Specific Cases of Spinocerebellar Ataxia (SCA)*
8.4.5. Diagnosed Cases of Spinocerebellar Ataxia (SCA)
8.4.6. Treated Cases of Spinocerebellar Ataxia (SCA)
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Spinocerebellar Ataxia (SCA)
8.5.3. Sub-Type Specific cases of Spinocerebellar Ataxia (SCA)*
8.5.4. Sex- Specific Cases of Spinocerebellar Ataxia (SCA)*
8.5.5. Diagnosed Cases of Spinocerebellar Ataxia (SCA)
8.5.6. Treated Cases of Spinocerebellar Ataxia (SCA)
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Spinocerebellar Ataxia (SCA)
9.3. Sub-Type Specific cases of Spinocerebellar Ataxia (SCA)*
9.4. Sex- Specific Cases of Spinocerebellar Ataxia (SCA)*
9.5. Diagnosed Cases of Spinocerebellar Ataxia (SCA)
9.6. Treated Cases of Spinocerebellar Ataxia (SCA)
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.